PMV Pharmaceuticals
$1.1800
8
-$0.05-4.07% Tuesday 20:00
Statistics
Day High
1.285
Day Low
1.18
52W High
1.8
52W Low
0.877
Volume
422,150
Avg. Volume
-
Mkt Cap
62.79M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6AugExpected
Expected EPS
-0.4
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-117.42MNet Income
Analyst Ratings
5.00Average Price Target
The highest estimate is 5.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PMVP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.42B
Intellia Therapeutics
NTLA
Mkt Cap1.85B
Editas Medicine
EDIT
Mkt Cap530.98M
Beam Therapeutics
BEAM
Mkt Cap3.39B
Allogene Therapeutics
ALLO
Mkt Cap748.99M
Sangamo Therapeutics
SGMO
Mkt Cap91.14M
Fate Therapeutics
FATE
Mkt Cap331.03M
Gilead Sciences
GILD
Mkt Cap166.9B
Biomarin Pharmaceutical
BMRN
Mkt Cap11.07B
About
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Show more...
CEO
Dr. David H. Mack Ph.D.
Employees
47
Country
United States
ISIN
US69353Y1038
Listings
0 Comments
Share your thoughts
FAQ
What is PMV Pharmaceuticals stock price today?▼
The current price of PMVP is $1.18 USD — it has decreased by -4.07% in the past 24 hours. Watch PMV Pharmaceuticals stock price performance more closely on the chart.
What is PMV Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PMV Pharmaceuticals stocks are traded under the ticker PMVP.
Is PMV Pharmaceuticals stock price growing?▼
PMVP stock has fallen by -1.67% compared to the previous week, the month change is a -15.11% fall, over the last year PMV Pharmaceuticals has showed a +28.36% increase.
What is PMV Pharmaceuticals market cap?▼
Today PMV Pharmaceuticals has the market capitalization of 62.79M
When is the next PMV Pharmaceuticals earnings date?▼
PMV Pharmaceuticals is going to release the next earnings report on August 06, 2026.
What were PMV Pharmaceuticals earnings last quarter?▼
PMVP earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.41 USD resulting in a +17.07% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PMV Pharmaceuticals revenue for the last year?▼
PMV Pharmaceuticals revenue for the last year amounts to 0 USD.
What is PMV Pharmaceuticals net income for the last year?▼
PMVP net income for the last year is -117.42M USD.
How many employees does PMV Pharmaceuticals have?▼
As of June 03, 2026, the company has 47 employees.
In which sector is PMV Pharmaceuticals located?▼
PMV Pharmaceuticals operates in the Health & Wellness sector.
When did PMV Pharmaceuticals complete a stock split?▼
PMV Pharmaceuticals has not had any recent stock splits.
Where is PMV Pharmaceuticals headquartered?▼
PMV Pharmaceuticals is headquartered in Princeton, United States.